87265-74-5

Upstream product

• 84784-84-9 (S)-5-Hydroxy-2,4-dimethyl-pent-1-en-3-one 
• 87265-67-6 2,3-anti-3,4-syn-4-methyl-5-trityloxypentan-2,3-diol 
• 92737-70-7 3-Hydroxy-2,4-dimethyl-pent-4-enoic acid tert-butyl ester 
• 87265-67-6 2,3-syn-3,4-syn-4-methyl-5-trityloxypentan-2,3-diol 
• 87265-69-8 (2S,3S,4R)-3-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-5-trityloxy-pentan-2-ol 
• 87265-64-3 t-butyl 2,4-dimethyl-3-oxo-4-pentanoate 
• 92737-73-0 Methanesulfonic acid (1R,2S)-1-[(R)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-2-methyl-3-trityloxy-propyl ester 
• 92737-73-0 Methanesulfonic acid (1R,2S)-1-[(S)-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-2-methyl-3-trityloxy-propyl ester 
• 121155-62-2 (3S,4R)-3-Hydroxy-4-methyl-5-trityloxy-pentan-2-one 
• 121103-78-4 methyl (2S,3S,E)-3-hydroxy-2,4-dimethyl-5-phenylpent-4-enoate 
• 121103-79-5 (E)-(2R,3R)-3-Acetoxy-2,4-dimethyl-5-phenyl-pent-4-enoic acid methyl ester 
• 121103-77-3 (E)-2,4-Dimethyl-3-oxo-5-phenyl-pent-4-enoic acid methyl ester 
• 92737-70-7 (2R,3R)-3-Hydroxy-2,4-dimethyl-pent-4-enoic acid tert-butyl ester 
• 87265-69-8 2,3-syn-3,4-syn-3-t-butyldimethylsilyloxy-4-methyl-5-trityloxy-2-pentanol 

Downstream Products

• 87265-79-0 (2S,3R,4R)-3-[1,3]Dithian-2-yl-4-methyl-5-trityloxy-pentan-2-ol 
• 87265-78-9 2,3-syn-3,4-anti-2,4-dimethyl-3-hydroxy-5-trityloxypentanal trimethylenedithioacetal 
• 87265-78-9 2,3-anti-3,4-anti-2,4-dimethyl-3-hydroxy-5-trityloxypentanal trimethylenedithioacetal 
• 87265-78-9 2,3-anti-3,4-syn-2,4-dimethyl-3-hydroxy-5-trityloxypentanal trimethylenedithioacetal 
• 87265-79-0 (2R,3S,4R)-3-[1,3]Dithian-2-yl-4-methyl-5-trityloxy-pentan-2-ol 
• 87265-78-9 2,3-syn-3,4-syn-2,4-dimethyl-3-hydroxy-5-trityloxypentanal trimethylenedithioacetal 
• 121103-82-0 (2R,3R,4R,6R)-2,4,6-Trimethyl-1-trityloxy-oct-7-en-3-ol 
• 121129-17-7 (2R,3R,5R)-5-Methyl-3-((S)-1-methyl-2-trityloxy-ethyl)-hept-6-en-2-ol 

Relevant academic research and scientific papers

DETERMINATION OF ABSOLUTE STRUCTURE OF C16-C22 PART OF IRUMAMYCIN. CHIRAL SYNTHESIS OF DEGRADATION PRODUCT

Absolute structure of C16-C22 part of Irumamycin (1) was determined by comparing the degradation product 2 with the synthetic (+)-2.

STEREOSELECTIVE ACYCLIC KETONE REDUCTION. SYNTHESIS OF THE SYNTHONS HAVING THREE CONSECUTIVE CHIRAL CENTERS

Four possible diastereomers of a functionalized 1,3-dimethyl-2-hydroxy unit were synthesized based on the stereoselective reduction of various acyclic ketones (i.e. reduction of β-keto ester, β-hydroxy ketone, α-hydroxy ketone, and α-silyloxy ketone) and

STEREOSELECTIVE SYNTHESIS OF THE SYNTHONS HAVING THREE CONSECTIVE CHIRAL CENTERS

Four possible diastereomers having three consective chiral centers, R-CHMe-CHOH-CHMe-R', have been synthesized stereoselectively based on the stereoselective reduction of acyclic ketones.